Table 2.
Parameters During In Vitro Fertilization in Polycystic Ovary Syndrome Women With or Without Central Obesity
| Central obesity (n = 70) | Noncentral obesity (n = 118) | |
|---|---|---|
| Cycle cancellation for poor response (n, %) | 1 (1.4) | 3 (2.5) |
| Total dose of gonadotropin (IU) | 2014.8 ± 825.8* | 1491.2 ± 558.9* |
| Duration of gonadotropin stimulation (days) | 12.5 ± 4.0* | 10.7 ± 3.0* |
| Peak E2 (pg/mL) | 2320.4 ± 1303.6* | 3256.3 ± 1456.0* |
| Endometrial thickness (mm) | 11.7 ± 3.0 | 11.5 ± 2.8 |
| Dose of hCG (IU) | 6869.6 ± 1971.6** | 6134.8 ± 1652.1** |
| No. of mature follicles | 9.6 ± 4.6** | 11.5 ± 5.2** |
| No. of completed cycles (n, %) | 69 (98.6) | 115 (97.5) |
| No. of ICSI cycles (n, %) | 12 (17.1) | 23 (19.5) |
| No. of oocytes retrieved | 11.6 ± 5.7** | 13.8 ± 7.3** |
| Fertilization rate (%) | 0.64 ± 0.24 | 0.61 ± 0.21 |
| Cleavage rate (%) | 0.96 ± 0.16 | 0.97 ± 0.14 |
| No. of frozen embryos | 4.72 ± 4.50 | 5.98 ± 5.35 |
| Percentage of embryos available | 0.74 ± 0.23 | 0.73 ± 0.22 |
| No. of high quality embryos | 3.67 ± 3.14 | 4.03 ± 3.96 |
Values are expressed as mean ± SD or numbers (percentages).
*
Significant differences between two groups, p < 0.01.
**
Significant differences between two groups, p < 0.05.
E2, estradiol; hCG, human chorionic gonadotropin; ICSI, intracytoplasmic sperm injection.